Celgene Corporation (CELG)
Celgene Corporation Stock Buybacks
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CELG Stock Buybacks Range, Past 5 Years
| Minimum | 31.55M | Sep 2009 |
| Maximum | 847.39M | Sep 2011 |
| Average | 262.80M |
About Stock Buybacks
Stock buybacks occur when companies buy back their own stock, removing it from the marketplace. Stock buybacks can increase the value of the remaining shares because company earnings are split among fewer shares.
Buybacks are sometimes an indication that a company perceives their stock to be undervalued, but it is up to the investor to determine if the company is correct.
Learn More
You may also be interested in these CELG related companies
CELG News
@Urbane_Gorilla http://stks.co/3z5t $CYCC $CELG $BMY $REGN $PFE #ASCO12 checklist
about 3 days ago by biotech
about 3 days ago by biotech
How I rolled the short side of my diagonal spreads to June http://stks.co/3xhz $AAPL $FFIV $RVBD $BRCM $CELG $POT $YNDX $MON
about 5 days ago by monthlyspreads
about 5 days ago by monthlyspreads
$CELG http://stks.co/3wmz Bounced nicely off the 200sma.If it can clear the recent high,I think it can get to the 50 sma at 75
about 5 days ago by ACInvestorBlog
about 5 days ago by ACInvestorBlog
$CELG under a lot of pressure lately; trying to firm up at 200-day SMA
about 7 days ago by Kenshreve
about 7 days ago by Kenshreve
$celg Forget about 200SMA support. Here's the fundy: ASCO in early June, Pomalidomide in FDA hands, Apremilast soon to be the new Rev.
about 9 days ago by ForexChemist
about 9 days ago by ForexChemist
RT @upsidetrader NEW POST: IS BIG BIOTECH READY TO FAIL? http://stks.co/3rgZ $IBB $CELG $SPX, $QQQ $BIIB $ALXN
about 12 days ago by packerfan48051
about 12 days ago by packerfan48051
Having said that, BEHOLD the double-top-a-thon! $CELG http://chart.ly/n6iu35y
about 12 days ago by TraderMommy
about 12 days ago by TraderMommy
NEW POST: IS BIG BIOTECH READY TO FAIL? http://stks.co/3reR $IBB $CELG $SPX, $QQQ $BIIB $ALXN
about 12 days ago by upsidetrader
about 12 days ago by upsidetrader
I'm not happy with this market at the moment. $CELG, $AGN, $ALGN, $AAPL... and let's just forget about the oil/gas stocks
about 13 days ago by jmmccargar
about 13 days ago by jmmccargar
Zack analysts pleased with $CELG oncology portfolio but cited concern about decline in sales of Thalomid and loss of exclusivity of Vidaza.
about 16 days ago by abubnic
about 16 days ago by abubnic
Zack's Research reiterates neutral rating on $CELG with a price target of $74.
about 16 days ago by abubnic
about 16 days ago by abubnic
Celgene (CELG) Unit Reports Publication of Three REVLIMID Studies in MM Patients
May 10, 7:42AM Street Insider
May 10, 7:42AM Street Insider
May positions: http://stks.co/3i3Y not a great earnings period so far, resisting urge to sell lower strike calls $BRCM $CELG $YUM $POT $MON
about 21 days ago by monthlyspreads
about 21 days ago by monthlyspreads
@jimcramer 's $ABT in trouble. His $COG and $CELG also still terrible recomendations. Worst in my port.
about 21 days ago by epime7heus
about 21 days ago by epime7heus
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CELG | 68.90 | -1.01 | -1.44% | 30.23B |
| CEL | 7.55 | -0.07 | -0.92% | 751.07M |
| COP | 52.11 | -0.03 | -0.06% | 66.68B |
| COOL | 2.08 | +0.02 | +0.97% | 85.97M |
| COO | 85.53 | -0.21 | -0.24% | 4.093B |
| CONN | 17.71 | -0.04 | -0.23% | 566.19M |
| CONG | 50.80 | +0.04 | +0.08% | |
| COMV | 1.74 | +0.00 | +0.00% | 47.87M |
| COLM | 48.90 | +0.24 | +0.49% | 1.649B |
| COLB | 18.13 | -0.11 | -0.60% | 719.22M |
